Poll results: What is your first-line approach to emergent presbyopes who wear contact lenses?

Article

See our latest poll results

Optometry Times® polled our audience with the following question from July 27, 2021 to August 13, 2021:​ What is your first-line approach to emergent presbyopes who wear contact lenses?

The poll appeared on optometrytimes.com and was promoted on various social media channels. Results show a majority of responding ODs' first-line approach to emergent presbyopies who wear contact lenses is multifocal contact lenses.

44 ODs responded, in total. Of these:

• 23 responded "Multifocal contact lenses"

• 10 responded "Monovision contact lenses"

• 10 responded "Low-power readers over single-vision contact lenses"

• 1 responded "Low-power readers over single-vision contact lenses"

Check out our latest poll: Have you or do you plan to implement myopia control into your practice?

Recent Videos
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Dr. Mile Brujic discusses a case series on a novel gel for lacrimal occlusion.
Dr. Julie Rodman previews her SECO presentations
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
© 2025 MJH Life Sciences

All rights reserved.